Piramal Enterprises is seeking shareholders' nod to raise Rs 1,750 crore from a Canadian investor by issuing compulsorily convertible debentures (CCDs). An extraordinary general meeting is scheduled to be held on November 25 in Mumbai. The company requires additional funding for various purposes, including general corporate purposes, in view of its future outlook, growth targets and prospects.
Piramal Enterprises is one of India’s large diversified companies, with a presence in Pharmaceuticals, Healthcare Information Management and Financial Services.